Covered recipient · General Payments record
FRANK ANDERSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,580.30
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $221.68 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $62.48 | 3 |
| Acerta Pharma LLC | $60.43 | 3 |
| GlaxoSmithKline, LLC. | $36.24 | 2 |
| PFIZER INC. | $18.10 | 1 |
| Exact Sciences Corporation | $15.67 | 1 |
| ABBVIE INC. | $14.73 | 1 |
| Abbott Laboratories | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.03 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125093923 | CMS |
| ABBVIE INC. | $14.73 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103223335 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105544725 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.27 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104562042 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105849832 | CMS |
| Exact Sciences Corporation | $15.67 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114576607 | CMS |
| GlaxoSmithKline, LLC. | $17.48 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116624567 | CMS |
| GlaxoSmithKline, LLC. | $18.76 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116517270 | CMS |
| Lilly USA, LLC | $22.22 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134983148 | CMS |
| Lilly USA, LLC | $21.22 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134983150 | CMS |
| Lilly USA, LLC | $19.04 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134982106 | CMS |
| PFIZER INC. | $18.10 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130887150 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.